Filing Details
- Accession Number:
- 0001140361-13-011594
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-08 17:40:04
- Reporting Period:
- 2013-03-06
- Filing Date:
- 2013-03-08
- Accepted Time:
- 2013-03-08 17:40:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1240122 | G Michael Grey | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-03 | 15,000 | $14.39 | 34,650 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-06 | 15,000 | $60.61 | 19,650 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-03-06 | 15,000 | $0.00 | 15,000 | $14.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-05-12 | 2019-05-11 | No | 4 | M | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually received ranged from $60.30 to $61.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vests 1/4 every 90 days.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.